This content is PDF only. Please click on the PDF icon to access.
Live, attenuated rubella virus vaccine1 appears to be a highly effective immunizing agent and the first suitable method of controlling rubella. Through June 1970 more than 19 million doses of vaccine have been distributed in the United States.
Rubella is generally a mild illness, but if the infection is acquired by a woman in the early months of pregnancy, it poses a direct hazard to the fetus. Preventing infection of the fetus is the principal objective of rubella control. This can best be achieved by eliminating the transmission of virus among children, who are the major source of infection for
Rubella Virus Vaccine: Recommendation of the Advisory Committee on Immunization Practices, U.S. Public Health Service. Ann Intern Med. ;73:779–781. doi: 10.7326/0003-4819-73-5-779
Download citation file:
Published: Ann Intern Med. 1970;73(5):779-781.
Infectious Disease, Prevention/Screening, Vaccines/Immunization.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use